 Connection
Larry Moreland to Research Design
This is a "connection" page, showing publications Larry Moreland has written about Research Design.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.088 |
|
|
|
-
Cronholm PF, Applequist J, Krischer J, Fontenot E, Davis T, Burroughs C, McAlear CA, Borchin R, Kullman J, Carette S, Khalidi N, Koening C, Langford CA, Monach P, Moreland L, Pagnoux C, Specks U, Sreih AG, Ytterberg SR, Merkel PA. A study of implementation factors for a novel approach to clinical trials: constructs for consideration in the coordination of direct-to-patient online-based medical research. BMC Med Res Methodol. 2024 Oct 18; 24(1):244.
Score: 0.035
-
Vignon EP, Moreland L. How do we best measure the clinical benefit of a structure-modifying osteoarthritis drug? Osteoarthritis Cartilage. 2004; 12 Suppl A:S61-2.
Score: 0.033
-
Moreland L, Alarcón GS. Comment on the article by Furst et al. Arthritis Rheum. 1989 Dec; 32(12):1631-2.
Score: 0.012
-
Clements PJ, Seibold JR, Furst DE, Mayes M, White B, Wigley F, Weisman MD, Barr W, Moreland L, Medsger TA, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Wong WK. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned. Semin Arthritis Rheum. 2004 Feb; 33(4):249-63.
Score: 0.008
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|